Works matching IS 03065251 AND DT 2020 AND VI 86 AND IP 9

Results: 26

Opportunities for using in silico‐based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1769, doi. 10.1111/bcp.14369

By:

Peer, Cody J.;
Goldstein, Daniel A.;
Goodell, Jennifer C.;
Nguyen, Ryan;
Figg, William D.;
Ratain, Mark J.

Publication type:

Article

Issue Highlights.

Published in:: British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1671, doi. 10.1111/bcp.14520
Publication type:: Article

Correction.

Published in:: British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1894, doi. 10.1111/bcp.14497
Publication type:: Article

Taking the brake off the immune system: Hypotheses, trials, tribulations, and the evolving discipline of clinical immunopharmacology.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1674, doi. 10.1111/bcp.14481

By:

Martin, Jennifer H.;
Lewis, Lionel D.

Publication type:

Article

Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1778, doi. 10.1111/bcp.14433

By:

Mangan, Brendan L.;
McAlister, Renee K.;
Balko, Justin M.;
Johnson, Douglas B.;
Moslehi, Javid J.;
Gibson, Andrew;
Phillips, Elizabeth J.

Publication type:

Article

Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1753, doi. 10.1111/bcp.14355

By:

Watson, Geoffrey Alan;
Doi, Jeffrey;
Hansen, Aaron Richard;
Spreafico, Anna

Publication type:

Article

Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID‐19 pandemic.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1790, doi. 10.1111/bcp.14353

By:

Eşkazan, Ahmet Emre

Publication type:

Article

Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1736, doi. 10.1111/bcp.14352

By:

Navani, Vishal;
Graves, Moira C.;
Bowden, Nikola A.;
Van Der Westhuizen, Andre

Publication type:

Article

Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1726, doi. 10.1111/bcp.14351

By:

Gómez, Valentí;
Mustapha, Rami;
Ng, Kenrick;
Ng, Tony

Publication type:

Article

Why we need to pay attention to toxicity associated with herbal medicines.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1793, doi. 10.1111/bcp.14340

By:

Enioutina, Elena Y.;
Job, Kathleen M.;
Sherwin, Catherine M.T.

Publication type:

Article

Scientifically based combination therapies with immuno‐oncology checkpoint inhibitors.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1711, doi. 10.1111/bcp.14338

By:

Chew, Hui Yi;
Dolcetti, Riccardo;
Simpson, Fiona

Publication type:

Article

Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1703, doi. 10.1111/bcp.14337

By:

Kim, Hansoo;
Liew, Danny;
Goodall, Stephen

Publication type:

Article

Mechanism‐based treatment of cancer with immune checkpoint inhibitor therapies.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1690, doi. 10.1111/bcp.14316

By:

Abdou, Yara;
Pandey, Manu;
Sarma, Maithreyi;
Shah, Shrunjal;
Baron, Jeffrey;
Ernstoff, Marc S.

Publication type:

Article

Expanded Access as a source of real‐world data: An overview of FDA and EMA approvals.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1819, doi. 10.1111/bcp.14284

By:

Polak, Tobias B.;
Rosmalen, Joost;
Uyl – de Groot, Carin A.

Publication type:

Article

Unexpected overdose blood concentration of tacrolimus: Keep in mind the role of inflammation.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1888, doi. 10.1111/bcp.14292

By:

Bonneville, Edouard;
Gautier‐Veyret, Elodie;
Ihl, Cordelia;
Hilleret, Marie‐Noelle;
Baudrant, Magalie;
Fonrose, Xavier;
Stanke‐Labesque, Françoise

Publication type:

Article

Safety, pharmacokinetics and pharmacodynamics of branebrutinib (BMS‐986195), a covalent, irreversible inhibitor of Bruton's tyrosine kinase: Randomised phase I, placebo‐controlled trial in healthy participants.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1849, doi. 10.1111/bcp.14290

By:

Catlett, Ian M.;
Nowak, Miroslawa;
Kundu, Sudeep;
Zheng, Naiyu;
Liu, Ang;
He, Bing;
Girgis, Ihab G.;
Grasela, Dennis M.

Publication type:

Article

Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1836, doi. 10.1111/bcp.14289

By:

Mahalingam, Devalingam;
Patel, Manish R.;
Sachdev, Jasgit C.;
Hart, Lowell L.;
Halama, Niels;
Ramanathan, Ramesh K.;
Sarantopoulos, John;
Völkel, Dirk;
Youssef, Ashraf;
Jong, Floris A.;
Tsimberidou, Apostolia Maria

Publication type:

Article

Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1827, doi. 10.1111/bcp.14288

By:

Geers, Lisanne M.;
Pozhidaev, Ivan V.;
Ivanova, Svetlana A.;
Freidin, Maxim B.;
Schmidt, Amand F.;
Cohen, Dan;
Boiko, Anastasiia S.;
Paderina, Diana Z.;
Fedorenko, Olga Yu;
Semke, Arkadiy V.;
Bokhan, Nikolay A.;
Wilffert, Bob;
Kosterink, Jos G.W.;
Touw, Daan J.;
Loonen, Anton J.M.

Publication type:

Article

Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y<sub>12</sub> inhibitor.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1860, doi. 10.1111/bcp.14296

By:

Zhang, Yifan;
Zhu, Xiaoxue;
Zhan, Yan;
Li, Xiaojiao;
Liu, Cai;
Zhu, Yunting;
Zhang, Hong;
Wei, Haijing;
Xia, Yu;
Sun, Hongbin;
Liu, Yongqiang;
Lai, Xiaojuan;
Gong, Yanchun;
Liu, Xuefang;
Li, Yongguo;
Ding, Yanhua;
Zhong, Dafang

Publication type:

Article

Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1807, doi. 10.1111/bcp.14283

By:

Rolfo, Christian;
Isambert, Nicolas;
Italiano, Antoine;
Molife, L. Rhoda;
Schellens, Jan H.M.;
Blay, Jean‐Yves;
Decaens, Thomas;
Kristeleit, Rebecca;
Rosmorduc, Olivier;
Demlova, Regina;
Lee, Myung‐Ah;
Ravaud, Alain;
Kopeckova, Katerina;
Learoyd, Maria;
Bannister, Wendy;
Locker, Gershon;
Vos‐Geelen, Judith

Publication type:

Article

Chimeric antigen receptor T‐cell therapies: Optimising the dose.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1678, doi. 10.1111/bcp.14281

By:

Dasyam, Nathaniel;
George, Philip;
Weinkove, Robert

Publication type:

Article

Exposure–response characterisation of tildrakizumab in chronic plaque psoriasis: Pooled analysis of 3 randomised controlled trials.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1795, doi. 10.1111/bcp.14280

By:

Kerbusch, Thomas;
Li, Hanbin;
Wada, Russell;
Jauslin, Petra M.;
Wenning, Larissa

Publication type:

Article

Patterns of pregabalin initiation and discontinuation after its subsidy in Australia.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1882, doi. 10.1111/bcp.14276

By:

Chiu, Tricia;
Brett, Jonathan;
Pearson, Sallie‐Anne;
Schaffer, Andrea L.

Publication type:

Article

Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double‐blind randomized clinical trial.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1875, doi. 10.1111/bcp.14238

By:

Shariati, Laleh;
Amouheidari, Alireza;
Naji Esfahani, Hajar;
Abed, Alireza;
Haghjooy Javanmard, Shaghayegh;
Laher, Ismail;
Ghasemi, Ahmad;
Vaseghi, Golnaz

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1669, doi. 10.1111/bcp.14011
Publication type:: Article

Pharmacokinetic herb‐drug interaction between ginger and crizotinib.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1892, doi. 10.1111/bcp.13862

By:

Revol, Bruno;
Gautier‐Veyret, Elodie;
Arrivé, Capucine;
Fouilhé Sam‐Laï, Nathalie;
McLeer‐Florin, Anne;
Pluchart, Hélène;
Pinsolle, Julian;
Toffart, Anne‐Claire

Publication type:

Article